Cargando…

Trends in overall survival and costs of multiple myeloma, 2000–2014

Little real-world evidence is available to describe the recent trends in treatment costs and outcomes for patients with multiple myeloma (MM). Using the Truven Health MarketScan Research Databases linked with social security administration death records, this study found that the percentage of MM pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonseca, R, Abouzaid, S, Bonafede, M, Cai, Q, Parikh, K, Cosler, L, Richardson, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596206/ https://www.ncbi.nlm.nih.gov/pubmed/28008176 http://dx.doi.org/10.1038/leu.2016.380

Ejemplares similares

Time-dependent endpoints as predictors of overall survival in multiple myeloma
por: Félix, Jorge, et al.
Publicado: (2013)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019)

The independent association of mean platelet volume with overall survival in multiple myeloma
por: Zhuang, Qiang, et al.
Publicado: (2016)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Wang, Bei, et al.
Publicado: (2022)

Weight Trends in Veterans With and Without Diabetes, 2000-2014
por: Tamas, Margery J., et al.
Publicado: (2018)

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
por: Cramer-van der Welle, Christine M., et al.
Publicado: (2020)

Rising trends in pancreatic cancer incidence and mortality in 2000–2014
por: Wu, Wenrui, et al.
Publicado: (2018)

Mapping disparities in homicide trends across Brazil: 2000–2014
por: Nsoesie, Elaine Okanyene, et al.
Publicado: (2020)

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population
por: Sørrig, Rasmus, et al.
Publicado: (2017)

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma
por: Li, Yang, et al.
Publicado: (2021)

PB2119: REDUCED OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS DURING THE COVID-19 PANDEMIC
por: Luchinin, Alexander, et al.
Publicado: (2023)

Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma
por: Fonseca, Rafael, et al.
Publicado: (2023)

Trends in Hospitalizations for Acute Kidney Injury — United States, 2000–2014
por: Pavkov, Meda E., et al.
Publicado: (2018)

Evaluation of Colorectal Cancer Incidence Trends in the United States (2000–2014)
por: Ansa, Benjamin E., et al.
Publicado: (2018)

Frequency and trends of hospital treated pesticide poisonings in Germany 2000–2014
por: Moebus, Susanne, et al.
Publicado: (2017)

Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014
por: Fu, Michael, et al.
Publicado: (2022)

Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014
por: Kanjilal, Sanjat, et al.
Publicado: (2017)

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
por: Ozaki, S, et al.
Publicado: (2015)

Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study
por: Zakaria, Hesham Mostafa, et al.
Publicado: (2018)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2020)

Development of a prognostic model for overall survival in multiple myeloma using the Connect(®) MM Patient Registry
por: Terebelo, Howard R., et al.
Publicado: (2019)

NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma
por: Jian, Xingxing, et al.
Publicado: (2022)

The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma
por: Ipek, Yildiz, et al.
Publicado: (2023)

Amplification of Chromosome 1q Predicts Poor Overall Survival in Newly Diagnosed Multiple Myeloma Patients
por: Skerget, Matevz, et al.
Publicado: (2023)

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome
por: Paquin, Ashley R., et al.
Publicado: (2018)

Trends in Overall Survival among Patients Treated for Sarcoma at a Large Tertiary Cancer Center between 1986 and 2014
por: Stricker, Erik, et al.
Publicado: (2023)

Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of TP53
por: Ashby, Cody, et al.
Publicado: (2019)

Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality — United States, 2000–2014
por: Benoit, Stephen R., et al.
Publicado: (2018)

Temporal trends in step test performance for Chinese adults between 2000 and 2014
por: Liu, Yang, et al.
Publicado: (2021)

Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
por: Xu, Jiaxuan, et al.
Publicado: (2022)

Trends in the incidence and survival of multiple myeloma in South East England 1985-2004
por: Renshaw, Christine, et al.
Publicado: (2010)

Overall economic perspective to the year 2000 /
Publicado: (1988)

Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma
por: Kim, Sung Min, et al.
Publicado: (2014)

Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival
por: Kiba, Takayoshi, et al.
Publicado: (2014)

Erratum: Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study
Publicado: (2018)

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients
por: Qi, Tingting, et al.
Publicado: (2020)

Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma
por: Richardson, Paul G., et al.
Publicado: (2020)

Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial
por: Dimopoulos, Meletios A., et al.
Publicado: (2023)

Trends in Fetal Growth Between 2000 to 2014 in Singleton Live Births from Israel
por: Agay-Shay, Keren, et al.
Publicado: (2018)

Trends in Overall and Menthol Market Shares of Leading Cigarette Brands in the USA: 2014–2019
por: Miller Lo, Erin J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ukkqrv2qcqo94sph58qgleje49